SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-000258
Filing Date
2022-01-04
Accepted
2022-01-04 18:33:30
Documents
1
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 form4-01042022_030115.html 4  
1 form4-01042022_030115.xml 4 3134
  Complete submission text file 0001415889-22-000258.txt   4621
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 373 IVERNESS PARKWAY ENGLEWOOD CO 80112
Business Address
Cherevka Holli (Reporting) CIK: 0001717673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 22508364